Keros’ elritercept has shown promising efficacy signals in myelofibrosis and myelodysplastic syndromes and could pose a ...

Keros’ elritercept has shown promising efficacy signals in myelofibrosis and myelodysplastic syndromes and could pose a ...

Takeda ( TSE:4502/NYSE:TAK) today announced that it has entered into an exclusive licensing agreement with Keros Therapeutics, Inc. (Nasdaq: KROS) to further develop, manufacture and commercialize ...

Outcomes study will assess mortality and hospitalization in patients treated with Vafseo compared to current standard of care "We look forward to begin treating CKD anemia patients on dialysis with ...

AnemiaPhone, a technology developed by a multidisciplinary team of Cornell researchers to accurately, quickly and cheaply assess iron deficiency, has ...

Sotagliflozin, a dual SGLT1/2 inhibitor, increased hemoglobin levels in patients with type 2 diabetes and chronic kidney ...

Crohn’s disease may be a lifelong condition, but today, there are an abundance of effective treatments that can help bring relief to your symptoms and reduce your risk of experiencing more serious ...

AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as kidney stones or blood clots, low blood pressure, or heart disease. It ...

A breath of pressurized, oxygen-rich air can change the lives of patients with PTSD and many other conditions.

When it comes to managing prostate cancer, there is no one-size-fits-all approach. Men must consider a variety of factors ...

UPPER PENINSULA, Mich. (WLUC) - Tuesday was Iron Deficiency Day, and a U.P. doctor is spreading awareness about anemia. UP ...